ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
INTACT-TAA: A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
Protocol ID
INTACT-TAA
Condition/s
Acute Myelocytic Leukemia (AML)
Diagnosis Stage
Relapse/ refractory
Sponsor
University of Sydney
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 70 Years
International registry ID's
NCT02895412
Back to Registry
Study Title INTACT-TAA: A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
Protocol ID INTACT-TAA
Disease (Sub Disease) Acute Myelocytic Leukemia (AML)
Diagnosis Stage Relapse/ refractory
Sponsor University of Sydney
Links https://clinicaltrials.gov/ct2/show/NCT02895412
Trial Status Closed to Recruitment
Trial Open Date 01/03/2017
Study Type Treatment
Phase Phase 1
Age Eligibility 1 Year to 70 Years
International registry ID's NCT02895412

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168